Day One Biopharmaceuticals, Inc.
DAWN
$9.73
$0.748.23%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 31.11% | 2,190.50% | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 31.11% | 2,190.50% | -- | -- | -- |
| Cost of Revenue | 514.32% | 1,487.13% | -- | -- | -- |
| Gross Profit | 19.97% | 2,256.94% | -- | -- | -- |
| SG&A Expenses | 7.69% | 20.39% | 40.61% | 52.83% | 53.91% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -2.95% | 1.24% | 59.25% | 66.66% | 62.93% |
| Operating Income | 19.78% | 61.14% | 13.70% | -3.01% | -9.07% |
| Income Before Tax | -73.74% | 46.12% | 70.36% | 53.23% | 52.08% |
| Income Tax Expenses | 866.27% | 260.31% | -- | -- | -- |
| Earnings from Continuing Operations | -80.04% | 43.28% | 66.94% | 49.45% | 51.70% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -80.04% | 43.28% | 66.94% | 49.45% | 51.70% |
| EBIT | 19.78% | 61.14% | 13.70% | -3.01% | -9.07% |
| EBITDA | 20.97% | 62.11% | 14.74% | -2.27% | -8.59% |
| EPS Basic | -44.69% | 53.48% | 73.65% | 56.61% | 55.62% |
| Normalized Basic EPS | -48.13% | 54.51% | 75.98% | 62.08% | 58.51% |
| EPS Diluted | -43.96% | 53.43% | 73.57% | 56.57% | 55.46% |
| Normalized Diluted EPS | -47.93% | 54.44% | 75.93% | 62.02% | 58.45% |
| Average Basic Shares Outstanding | 15.47% | 17.08% | 16.56% | 16.91% | 17.19% |
| Average Diluted Shares Outstanding | 15.36% | 17.17% | 16.66% | 17.01% | 17.29% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |